Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Biomedicines|July 29, 2023
Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers-Improvements in Clinical Efficacy and SafetyMd Sazzad Hassan, Niranjan Awasthi, Saisantosh Ponna, et al.
Oncology Reports|October 6, 2023
Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)Joshua Zhang, Lily Darman, Md Sazzad Hassan, et al.
International Journal of Molecular Sciences|November 13, 2025
Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1Lily Darman, Quinn Kaurich, Md Sazzad Hassan, et al.
Cells|February 12, 2026
Targeting the c-Met/VEGFR Pathway to Boost <i>Nab</i>-Paclitaxel Efficacy in Gastric Cancer: Preclinical InsightsJennifer Huang, Quinn Kaurich, Md Sazzad Hassan, et al.
Cancer Research|October 14, 2010
Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snailCheng Du, Chuanyou Zhang, Sazzad Hassan, et al.
International Urology and Nephrology|September 24, 2013
A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsiesSazzad Hassan, Yelena Karpova, Anabel Flores, et al.
Biochemical and Biophysical Research Communications|July 8, 2008
Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cellsPaul Mak, Meena Jaggi, Viqar Syed, et al.
Journal of Medicinal Chemistry|August 29, 2012
Synthesis and characterization of a novel prostate cancer-targeted phosphatidylinositol-3-kinase inhibitor prodrugDaniele Baiz, Tanya A Pinder, Sazzad Hassan, et al.
Pageof 4